Identification of Potential Kinase Inhibitors within the PI3K/AKT Pathway of Leishmania Species.
Ontology highlight
ABSTRACT: Leishmaniasis is a public health disease that requires the development of more effective treatments and the identification of novel molecular targets. Since blocking the PI3K/AKT pathway has been successfully studied as an effective anticancer strategy for decades, we examined whether the same approach would also be feasible in Leishmania due to their high amount and diverse set of annotated proteins. Here, we used a best reciprocal hits protocol to identify potential protein kinase homologues in an annotated human PI3K/AKT pathway. We calculated their ligandibility based on available bioactivity data of the reported homologues and modelled their 3D structures to estimate the druggability of their binding pockets. The models were used to run a virtual screening method with molecular
SUBMITTER: Ochoa R
PROVIDER: S-EPMC8301987 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA